 Stealth BioTherapeutics Corp NASDAQ:MITO Q2 2020 Earnings Conference Call August 6, 2020 8:30 AM ET Company Participants Henry Hess - Chief Legal Counsel Reenie McCarthy - Chief Executive Officer Rob Weiskopf - Chief Financial Officer Jim Carr - Chief Clinical Development Officer Conference Call Participants Matthew Luchini - BMO Charles Duncan - Cantor Fitzgerald Yi Chen - HC Wainwright Presentation Henry Hess Good morning. 